You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Digoxin Chiral Isolates as Improved Pharmaceuticals

    SBC: ACADEMIC PHARMACEUTICALS            Topic: N/A

    DESCRIPTION (provided by applicant): Digoxin is the first line pharmacologic therapy for CHF and AF. Digoxin increases cardiac contractility and blocks conduction through the AV node slowing the ventricular response to AF and thus slowing the rate of the beating ventricles permitting more time for the heart to fill. The recent Dig trial supports the use of digoxin in the treatment of CHF and the r ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  2. Nanoadsorbent and Microwave Technology to Capture and Recover Organic Vapors

    SBC: ADS Technoogies, Inc.            Topic: N/A

    Emissions of volatile organic compounds (VOCs) and hazardous air polutants (HAPS are a serioud environmental issue. These pollutants are requlated to protect human health and encourage the development of better control technologies. Current technologies to control thses emissions, until better materials are developed, include destructive and/or recovery-based technologies. Implementation of ads ...

    SBIR Phase I 2005 Environmental Protection Agency
  3. Vascular Permeability Normalization in Ischemic Stroke

    SBC: Advanced Life Sciences, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Stroke is the third leading cause of death in the United States and is the number one cause of adult disability. It is estimated that this clinical condition results in a cost of $30-40 billion in the U.S alone. While a large number of therapeutic agents have been investigated for the treatment of ischemic stroke, only one agent is currently approved for marke ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Barium Titanate Formation for Electronic/Photonic Applications

    SBC: INTEGRAL WAVE TECHNOLOGIES            Topic: MDA01014

    Integral Wave Technologies (for known as Arkansas Microelectronic Development Corporation) is developing a process for growing ferroelectric, polycrystalline barium titanate (BaTiO3) thin-films, by anodic oxidation of co-evaporated barium-titanium films (BaTi). Though films of this nature find applications in several electrical devices, Integral Wave will utilize this novel method of ferroelectri ...

    SBIR Phase II 2005 Department of DefenseMissile Defense Agency
  5. Multifunctional Protective Coatings for Spacecraft Surfaces

    SBC: APPLIED MATERIAL SYSTEMS ENGINEERING, INC.            Topic: MDA05T019

    The purpose of this STTR phase I proposal is to demonstrate the feasibility of producing the survivable multi-functional engineered material systems for spacecraft surfaces at an affordable cost using the proposed novel material designs and processes. The objectives of these efforts are not only to demonstrate the technical feasibility, but also to illustrate that at least 50% cost savings for DOD ...

    STTR Phase I 2005 Department of DefenseMissile Defense Agency
  6. Cerablak-Based Materials for Next Generation Radomes

    SBC: APPLIED THIN FILMS, INC            Topic: N03080

    A new material, based on a thermally-stable amorphous aluminophosphate composition (Cerablak™), was investigated in Phase I, and demonstrated highly desirable dielectric properties suitable for next-generation hypersonic radomes. Cerablak™ is a low cost, solution derived material which has a unique glass structure that is resistant to crystallization even at elevated temperatures. Building o ...

    SBIR Phase II 2005 Department of DefenseNavy
  7. Low Areal Density Passive Fire Insulation

    SBC: APPLIED THIN FILMS, INC            Topic: N04200

    The US Navy is seeking improved fire protection systems with the primary goal to reduce the areal density based on the current 1 lb/sq ft baseline value. Recent tests with intumescent coatings were largely unsuccessful. Passive fire protection systems are preferable due to their relatively inert nature during a fire event. New thermal concepts are needed to lower areal density of passive fire p ...

    SBIR Phase I 2005 Department of DefenseNavy
  8. Multifunctional, Low-Cost, Inorganic Seal Coatings for Radomes

    SBC: APPLIED THIN FILMS, INC            Topic: N05124

    Barrier coatings to prevent moisture ingress into radome structures of advanced missile systems are a critical need for the Navy. Ingress of moisture during missile storage can degrade the critical sensor and guidance electronic components housed within the missile radome. The US Navy is developing missiles targeted for varying flight conditions which utilize many radome materials. A versatile ...

    SBIR Phase I 2005 Department of DefenseNavy
  9. High-performance Food Pathogen Detection Instrument

    SBC: Biodetection Instruments, Inc            Topic: N/A

    DESCRIPTION (provided by applicant): The primary objective of this Phase II project is to develop an innovative benchtop instrument for use on-site at food processing facilities with high performance, ease-of-use, and a low per sample cost for rapid, specific, and sensitive detection of multiple pathogens including Escherichia coli O157:H7, Listeria monocytogenes, and Salmonella Typhimurium in re ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Point Source Ozonation to Minimize Antibiotic Resistance

    SBC: Biodetection Instruments, Inc            Topic: N/A

    DESCRIPTION (provided by applicant): BluelnGreen, LLC proposes to develop an effective, versatile and cost efficient device for the application of ozone micro-bubbles to the effluent of critical point sources of medical wastewater (hospitals, large clinics and pharmaceutical manufacturing plants) to reduce the overall amount of both antibiotic residuals and resistant pathogens that are released t ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government